GlassScriptPhysician profile
Kelly Garcia
NPI 1043625965
$529.79
in general payments reported to CMS, 2019-2025
11 companies · $93.17 in 2025
The $93.17 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $82.78 · 2021: $30.00 · 2022: $12.07 · 2023: $201 · 2024: $110 · 2025: $93.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $404.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $179.81 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Indivior INC. | $160.72 | 2019-2025 | Sublocade |
| Averitas Pharma INC. | $30.02 | 2024 | Qutenza |
| Abbott Laboratories | $30.00 | 2021 | |
| Exact Sciences Corporation | $29.64 | 2023-2024 | Cologuard Collection Kit |
| Lilly USA, LLC | $25.55 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.44 | 2019 | |
| Pfizer INC. | $16.82 | 2024 | |
| Novo Nordisk INC | $14.63 | 2019 | |
| Sanofi-Aventis U.S. LLC | $12.09 | 2019 | |
| Insulet Corporation | $12.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly Garcia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.